Combining phenomics with transcriptomics reveals cell-type-specific morphological and molecular signatures of the 22q11.2 deletion
- PMID: 40634302
- PMCID: PMC12241582
- DOI: 10.1038/s41467-025-61547-x
Combining phenomics with transcriptomics reveals cell-type-specific morphological and molecular signatures of the 22q11.2 deletion
Abstract
Neuropsychiatric disorders remain difficult to treat due to complex and poorly understood mechanisms. NeuroPainting is a high-content morphological profiling assay based on Cell Painting and optimized for human stem cell-derived neural cell types, including neurons, progenitors, and astrocytes. The assay quantifies over 4000 features of cell structure and organelle organization, generating a dataset suitable for phenotypic screening in neural models. Here, we show that, in studies of the 22q11.2 deletion-a strong genetic risk factor for schizophrenia-we observe cell-type-specific effects, particularly in astrocytes, including mitochondrial disruption, altered endoplasmic reticulum organization, and cytoskeletal changes. Transcriptomic analysis shows reduced expression of cell adhesion genes in deletion astrocytes, consistent with post-mortem brain data. Integration of RNA and morphology data suggests a link between adhesion gene dysregulation and mitochondrial abnormalities. These results illustrate how combining image-based profiling with gene expression analysis can reveal cellular mechanisms associated with genetic risk in neuropsychiatric disease.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: B.C., S.S., and A.E.C. serve as scientific advisors for companies that use image-based profiling and Cell Painting (A.E.C.: Recursion, SyzOnc, Quiver Bioscience, B.C.: Marble Therapeutics, and S.S.: Waypoint Bio, Dewpoint Therapeutics, Deepcell) and receive honoraria for occasional scientific visits to pharmaceutical and biotechnology companies. All other authors declare no competing interests.
Figures
Update of
-
Combining NeuroPainting with transcriptomics reveals cell-type-specific morphological and molecular signatures of the 22q11.2 deletion.bioRxiv [Preprint]. 2024 Nov 17:2024.11.16.623947. doi: 10.1101/2024.11.16.623947. bioRxiv. 2024. Update in: Nat Commun. 2025 Jul 9;16(1):6332. doi: 10.1038/s41467-025-61547-x. PMID: 39605350 Free PMC article. Updated. Preprint.
References
-
- Kadakia, A. et al. The economic burden of schizophrenia in the United States. J. Clin. Psychiatry83, 14458 (2022). - PubMed
-
- Cohen, B. M. & Öngür, D. The urgent need for more research on bipolar depression. Lancet Psychiatry5, e29–e30 (2018). - PubMed
-
- Kuperberg, M. et al. Psychotic symptoms during bipolar depressive episodes and suicidal ideation. J. Affect. Disord.282, 1241–1246 (2021). - PubMed
-
- McIntyre, R. S. et al. Bipolar disorders. Lancet396, 1841–1856 (2020). - PubMed
MeSH terms
Grants and funding
- 890477/Simons Foundation
- R01 MH128366/MH/NIMH NIH HHS/United States
- GM122547/U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS)
- R35 GM122547/GM/NIGMS NIH HHS/United States
- R01MH128366/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
LinkOut - more resources
Full Text Sources
Medical
